The Current Ratio as of December 2025 (TTM) for MegaPro Biomedical Co., Ltd (6827.TWO) is 4.34

According to MegaPro Biomedical Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 4.34. This represents a change of -56.05% compared to the average of 9.88 of the last 4 quarters.

MegaPro Biomedical Co., Ltd (6827.TWO) Historical Current Ratio (quarterly & annually)

How has 6827.TWO Current Ratio performed in the past?

The mean historical Current Ratio of MegaPro Biomedical Co., Ltd over the last ten years is 14.36. The current 4.34 Current Ratio has changed 2.92% with respect to the historical average. Over the past ten years (40 quarters), 6827.TWO's Current Ratio was at its highest in in the December 2022 quarter at 17.77. The Current Ratio was at its lowest in in the June 2025 quarter at 4.34.

MegaPro Biomedical Co., Ltd (6827.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of MegaPro Biomedical Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MegaPro Biomedical Co., Ltd (6827.TWO) Average Current Ratio

How has 6827.TWO Current Ratio performed in the past?

The current Current Ratio of MegaPro Biomedical Co., Ltd (6827.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MegaPro Biomedical Co., Ltd (6827.TWO) Current Ratio vs. Peers

How is 6827.TWO’s Current Ratio compared to its peers?

MegaPro Biomedical Co., Ltd’s Current Ratio is less than LabTurbo Biotech Corporation (14.89), less than Bio Preventive Medicine Corp. (19.06), greater than GeneReach Biotechnology Corp. (2.39), less than LAUNXP Biomedical Co., Ltd (7.53), greater than Lukas Biomedical Inc. (1.21), less than Great Novel Therapeutics Biotech & Medicals (30.32), greater than Enimmune corporation (1.41), greater than NeoCore Technology Co., Ltd. (1.45), less than NaviFUS Corp. (12.72), greater than Taiwan Advance Bio-Pharmaceutical Inc. (0.90),

Build a custom stock screener for MegaPro Biomedical Co., Ltd (6827.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MegaPro Biomedical Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MegaPro Biomedical Co., Ltd (6827.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MegaPro Biomedical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.